Seven Fleet Capital Management LP
Q2 2026 13F-HR Holdings
Net value change ($000)
+287,659
(90.4%)
New positions
24
Sold out positions
43
Turnover %
36.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CGON | 128,890 | 2513.9% |
| TNGX | 85,159 | 810.9% |
| RVMD | 37,470 | 476.9% |
| PHVS | 21,902 | 448.8% |
| LQDA | 13,369 | 188.6% |
| MIRM | 12,924 | NEW |
| ELVN | 12,113 | 188.4% |
| AVTX | 11,052 | 346.2% |
| ASMB | 10,345 | 664.0% |
| ABVX | 10,042 | 209.5% |
Top Reduces (Value $000, Stocks/ETFs)
| CG ONCOLOGY INC | -97,418 | -100.0% |
| TYRA | -7,495 | -100.0% |
| TANGO THERAPEUTICS INC | -6,290 | -100.0% |
| AVALO THERAPEUTICS INC | -5,376 | -100.0% |
| MINERVA NEUROSCIENCES INC | -5,358 | -100.0% |
| AGIO | -4,977 | -70.2% |
| PCVX | -4,524 | -71.8% |
| PHARVARIS N V | -4,067 | -100.0% |
| SLNO | -3,876 | -100.0% |
| ENLIVEN THERAPEUTICS INC | -3,734 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|